International Biotechnology (LON:IBT) Shares Cross Above Fifty Day Moving Average – Should You Sell?

International Biotechnology (LON:IBT)’s stock price passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of GBX 1,072.15 and traded as high as GBX 1,090. International Biotechnology shares last traded at GBX 1,080, with a volume of 29,593 shares changing hands.

International Biotechnology Price Performance

The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.32 and a current ratio of 0.11. The business’s 50 day simple moving average is GBX 1,072.15 and its 200-day simple moving average is GBX 1,012.37. The stock has a market capitalization of £340.80 million, a price-to-earnings ratio of 4.45 and a beta of 0.47.

International Biotechnology (LON:IBT) last posted its earnings results on Tuesday, November 3rd. The company reported GBX (10.22) EPS for the quarter. International Biotechnology had a return on equity of 44.12% and a net margin of 95.99%. The firm had revenue of GBX 46 million during the quarter. Research analysts anticipate that International Biotechnology will post 0.94 earnings per share for the current year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.